Pfizer has joined forces with German biotech company BioNTech to develop a potential RNA vaccine to prevent the spread of COVID-19. As they have already been working with the German partners since 2018 to develop an RNA influenza vaccine, they are well poised to quickly bring together their expertise to combat COVID-19.

Read more

Source: Pfizer

Nicole Verbeeck

Nicole Verbeeck

Nicole Verbeeck is Founder and Editor-in-Chief of Moonshot for Life, covering global health progress. She is also founder of Juneau Cayenne, a creative design, content and technology lab crafting innovative storytelling experiences for clients in healthcare and life sciences worldwide and she is a healthy food chef focusing on prevention of disease.

Share this with your network?

It might help your network to realize the next step of progress!